Lv21
200 积分 2021-06-03 加入
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
5个月前
已关闭
Further advances in epilepsy
7个月前
已完结
Lipid Nanoparticles: A Novel Approach for Brain Targeting
7个月前
已完结
子宫内膜异位症疼痛管理指南（2024年实践版）
7个月前
已完结
Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009
11个月前
已完结
Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease
11个月前
已关闭
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders
2年前
已完结
Atopic Dermatitis
2年前
已完结
The evolving atopic dermatitis management landscape
2年前
已完结
Atopic dermatitis and pregnancy
2年前
已完结
皖公网安备34019202002308
